Due to significant study heterogeneity, current published reports cannot reliably estimate the true prevalence of primary aldosteronism, necessitating better-designed prevalence studies.
This study demonstrates that it is pointless to claim low or high prevalence of primary aldosteronism based on published reports. Because of the significant impact of a diagnosis of primary aldosteronism on health care resources and the necessary facilities, our findings urge for a prevalence study whose design takes into account the factors identified in the meta-regression analysis.
Käyser et al. (Thu,) studied this question.